View |
|
DR-XY30066
|
Clobetasol Propionate
|
Clobenate
|
500 mcg/g (0.05% w/w)
|
Topical Cream
|
-
|
Micro Labs Limited
|
India
|
-
|
28 August 2019
|
29 September 2024
|
View |
|
DR-XY30076
|
Doxorubicin Hydrochloride
|
Dactorubin
|
10 mg
|
Lyopjilized Powder for Injection (IV)
|
-
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
-
|
03 February 2021
|
01 October 2026
|
View |
|
DR-XY30077
|
Doxorubicin Hydrochloride
|
Dactorubin
|
50 mg
|
Lyopjilized Powder For Injection (Iv)
|
-
|
Khandelwal Laboratories Pvt. Ltd.
|
India
|
-
|
08 February 2021
|
01 October 2026
|
View |
|
DR-XY30094
|
Paracetamol
|
Poro
|
250mg
|
Rectal Suppository
|
-
|
YSP Industries (M) Sdn. Bhd.
|
Malaysia
|
-
|
08 November 2019
|
05 October 2024
|
View |
|
DR-XY30095
|
Nidcor
|
Metformin Hydrochloride
|
500 mg
|
Film-Coated Tablet
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
20 May 2021
|
02 May 2026
|
View |
|
DR-XY30096
|
Fluocinolone Acetonide/Hydroquinone + Tretinoin
|
Tri-Luma
|
0.1mg/40mg/0.5mg per gram
|
Cream
|
Anti-Melasma
|
G Production Inc.
|
Canada
|
Automatic Renewal
|
20 August 2019
|
30 September 2024
|
View |
|
DR-XY30102
|
Cefoxitin (As Sodium)
|
Zepax
|
1g
|
Powder For Injection (I.M./I.V.)
|
-
|
Yoo Young Pharmaceutical Co., Ltd.
|
Korea
|
-
|
20 January 2020
|
07 October 2024
|
View |
|
DR-XY30121
|
Amlodipine (as besilate) + Atorvastatin (as calcium)
|
Norvasc Protect
|
5mg / 20mg
|
Tablet
|
Calcium Channel Blocker/ Lipid Regulating Agent
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Renewal
|
04 August 2024
|
30 September 2029
|
View |
|
DR-XY30122
|
Amlodipine (As Besilate) + Atorvastatin ( As Calcium)
|
Norvasc Protect
|
10mg / 20mg
|
Tablet
|
Calcium Channel Blocker/ Lipid Regulating Agent
|
Pfizer Manufacturing Deutschland GmbH
|
Germany
|
Automatic Renewal (Reconstruction)
|
15 February 2024
|
30 September 2024
|
View |
|
DR-XY30131
|
Erythromycin
|
None
|
5mg/g
|
Ophthalmic Ointment
|
-
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
-
|
28 October 2019
|
14 October 2024
|
View |
|
DR-XY30142
|
Sodium Chloride
|
Salinase
|
6.5mg/mL ( 0.65% w/v)
|
Solution For Nebulization
|
-
|
El Laboratories, Inc.
|
Philippines
|
-
|
14 October 2019
|
15 October 2024
|
View |
|
DR-XY30144
|
Diclofenac Sodium
|
Lofenax
|
25mg/mL
|
Solution For Injection
|
-
|
Geofman Pharmaceuticals
|
Pakistan
|
Automatic Renewal
|
10 November 2022
|
15 October 2027
|
View |
|
DR-XY30153
|
None
|
Ranitidine (As Hydrochloride)
|
75 mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
-
|
18 May 2021
|
19 October 2026
|
View |
|
DR-XY30158
|
Aciclovir
|
Covelay
|
800mg
|
Tablet
|
-
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
-
|
23 October 2019
|
19 December 2024
|
View |
|
DR-XY30163
|
Paracetamol
|
Poro
|
250 mg/5 mL
|
Suspension
|
Analgesic/Antipyretic
|
Y.S.P. Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
06 July 2024
|
21 October 2029
|
View |
|
DR-XY30165
|
Erdosteine
|
Ectrin
|
175 mg/5 mL
|
Powder for Oral Suspension
|
Mucolytic
|
Hizon Laboratories, Inc.
|
Philippines
|
Initial (from Monitored Release)
|
05 April 2022
|
20 October 2024
|
View |
|
DR-XY30170
|
Epirubicin Hydrochloride
|
Neoquabin
|
10 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
15 May 2024
|
21 October 2029
|
View |
|
DR-XY30171
|
Epirubicin Hydrochloride
|
Neoquabin
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
21 April 2024
|
21 October 2029
|
View |
|
DR-XY30177
|
Potassium Iodide/ Sodium Iodide
|
VISTALENS
|
3mg/ 3mg per mL
|
Ophthalmic Solution
|
Lens Nutrient
|
E.L. Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
20 June 2027
|
View |
|
DR-XY30184
|
Metoclopramide Hydrochloride
|
Liothyl
|
10mg Film-Coated
|
Tablet
|
Gastrokinetic
|
YSP Industries (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
14 June 2024
|
28 October 2029
|